Risk Factors and Medical Symptoms Associated With Electronic Vapor Product Use Among Adolescents and Young Adults

Clin Pediatr (Phila). 2021 Jun;60(6-7):279-289. doi: 10.1177/00099228211009681. Epub 2021 Apr 24.

Abstract

The use of electronic vapor products (EVPs) has increased dramatically in the past decade. The objectives of our study were to examine the frequency of EVP use; to identify demographic characteristics, risk-taking behaviors, and beliefs about vaping; and to determine symptoms associated with EVPs among adolescents. A questionnaire addressing these objectives was administered to a convenience sample of subjects aged 12 to 23 years. Among 494 completed questionnaires, 80% of responders were considered experimenters/nonusers (never tried or tried one time) and 20% were considered frequent users (at least once a month). We identified demographic features and risk-taking behaviors associated with EVP use. In the previous 6 months, frequent users were more likely to report headache, cough, sleep disturbances, dehydration, weakness, racing heart, chest pain, and tremors. Our findings provide evidence to support efforts to decrease EVP use through screening, education, and preventative strategies.

Keywords: adolescent; anticipatory guidance; electronic vapor product; risk factors; symptoms.

Publication types

  • Observational Study

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Cross-Sectional Studies
  • Dehydration / chemically induced*
  • Female
  • Heart Diseases / chemically induced*
  • Humans
  • Male
  • Muscle Weakness / chemically induced*
  • Nicotine / adverse effects*
  • Prospective Studies
  • Risk Factors
  • Sleep Wake Disorders / chemically induced*
  • Surveys and Questionnaires
  • Tremor / chemically induced*
  • Vaping / adverse effects*
  • Vaping / pathology
  • Young Adult

Substances

  • Nicotine